SuperworthResMed market cap RMD
Share price times shares outstanding: what the whole company sells for, since 2010.
- Today, Oct 23, 2026
- $36.5B
- Highest close in our data
- $43B
- Sep 2021
ResMed is worth $36.5B at the close on Oct 23, 2026, at $252.86 a share.
That is down 4% over the last year and down 5% over five years.
Its highest close in our data was $43B in Sep 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $36.5B | $27.4B | $39.6B | +2% |
| 2025 | $35.7B | $30.1B | $43B | +4% |
| 2024 | $34.2B | $24.5B | $37.6B | +35% |
| 2023 | $25.3B | $19.8B | $35.4B | −17% |
| 2022 | $30.5B | $28.8B | $38.2B | −20% |
| 2021 | $38B | $26.9B | $43B | +23% |
| 2020 | $30.8B | $16.5B | $31.7B | +37% |
| 2019 | $22.5B | $13.4B | $22.5B | +41% |
| 2018 | $16B | $12.4B | $16.5B | +33% |
| 2017 | $12B | $8.8B | $12.3B | +37% |
| 2016 | $8.7B | $7.3B | $9.9B | +17% |
| 2015 | $7.5B | $7.1B | $10.5B | −6% |
| 2014 | $8B | $6.1B | $8B | +20% |
| 2013 | $6.7B | $6.1B | $8B | +14% |
| 2012 | $5.9B | $4.1B | $6B | +39% |
| 2011 | $4.2B | $4.1B | $5.1B | −19% |
| 2010 | $5.2B | $4.9B | $5.4B | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest ResMed's size, closest first, today.
| Company | Market cap |
|---|---|
| RMDResMed | $36.5B |
| MDLNMedline | $44.8B |
| WSTWest Pharmaceutical Services | $27.6B |
| BDXBecton, Dickinson and | $54.2B |
| SOLVSolventum | $14.5B |
| PENPenumbra | $12.8B |
| COOCooper Companies | $11.6B |
| ALGNAlign Technology | $11B |
| GMEDGlobus Medical | $10.9B |
| PODDInsulet | $10.3B |
| ISRGIntuitive Surgical | $159.8B |
| Peer median | $13.7B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on ResMed
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.